Genetics of allergic disease

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2 SUPPL. 2, 2010, Pages

  Holloway, John W ^a   Yang, Ian A ^b,c   Holgate, Stephen T ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

epigenetics; genetic testing; genetics; Heritability; pharmacogenetics

Indexed keywords

ALLERGIC DISEASE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; CLONING; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; DRUG TARGETING; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENETICS; HERITABILITY; HUMAN; IMMUNE RESPONSE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN ALLERGY; TREATMENT RESPONSE;

ADAM PROTEINS; AIRWAY REMODELING; ANIMALS; BIOMARKERS, PHARMACOLOGICAL; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERSENSITIVITY; INTERMEDIATE FILAMENT PROTEINS; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROGNOSIS;

EID: 76749154877     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.10.071     Document Type: Article

References (137)

1. Salter H.H. On asthma: its pathology and treatment (1860), John Churchil & Sons, London
2. Chavanas S., Bodemer C., Rochat A., Hamel-Teillac D., Ali M., Irvine A.D., et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25 (2000) 141-142
3. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 (2008) 773-776
4. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448 (2007) 1058-1062
5. Smith F.J., Irvine A.D., Terron-Kwiatkowski A., Sandilands A., Campbell L.E., Zhao Y., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38 (2006) 337-342
6. Skadhauge L.R., Christensen K., Kyvik K.O., and Sigsgaard T. Genetic and environmental influence on asthma: a population-based study of 11,688 Danish twin pairs. Eur Respir J 13 (1999) 8-14
7. Hanson B., McGue M., Roitman-Johnson B., Segal N.L., Bouchard Jr. T.J., and Blumenthal M.N. Atopic disease and immunoglobulin E in twins reared apart and together. Am J Hum Genet 48 (1991) 873-879
8. Lawrence S., Beasley R., Doull I., Begishvili B., Lampe F., Holgate S.T., et al. Genetic analysis of atopy and asthma as quantitative traits and ordered polychotomies. Ann Hum Genet 58 (1994) 359-368
9. Burney P., Chinn S., Luczynska C., Jarvis D., Vermeire P., Bousquet J., et al. Genes for asthma? An analysis of the European Community Respiratory Health Survey. Am J Respir Crit Care Med 156 (1997) 1773-1780
10. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 8 (2008) 169-182
11. Cookson W.O., Sharp P.A., Faux J.A., and Hopkin J.M. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1 (1989) 1292-1295
12. Ober C., and Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 7 (2006) 95-100
13. Cardon L.R., and Bell J.I. Association study designs for complex disease. Nat Rev Genet 2 (2001) 91-99
14. Holloway J.W., and Koppelman G.H. Identifying novel genes contributing to asthma pathogenesis. Curr Opin Allergy Clin Immunol 7 (2007) 69-74
15. Rogers A.J., Raby B.A., Lasky-Su J.A., Murphy A., Lazarus R., Klanderman B.J., et al. Assessing the reproducibility of asthma candidate gene associations using genome-wide data. Am J Respir Crit Care Med 179 (2009) 1084-1090
16. Ober C. Susceptibility genes in asthma and allergy. Curr Allergy Asthma Rep 1 (2001) 174-179
17. Van Eerdewegh P., Little R.D., Dupuis J., Del Mastro R.G., Falls K., Simon J., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418 (2002) 426-430
18. Ober C., Tan Z., Sun Y., Possick J.D., Pan L., Nicolae R., et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 358 (2008) 1682-1691
19. Allen M., Heinzmann A., Noguchi E., Abecasis G., Broxholme J., Ponting C.P., et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet 35 (2003) 258-263
20. Nicolae D., Cox N.J., Lester L.A., Schneider D., Tan Z., Billstrand C., et al. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 76 (2005) 349-357
21. Zhang Y., Leaves N.I., Anderson G.G., Ponting C.P., Broxholme J., Holt R., et al. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat Genet 34 (2003) 181-186
22. Oguma T., Palmer L.J., Birben E., Sonna L.A., Asano K., and Lilly C.M. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 351 (2004) 1752-1763
23. Barton S.J., Koppelman G.H., Vonk J.M., Browning C.A., Nolte I.M., Stewart C.E., et al. PLAUR polymorphisms are associated with asthma, PLAUR levels, and lung function decline. J Allergy Clin Immunol 123 (2009) 1391-1400 e17
24. Koppelman G.H., Meyers D.A., Howard T.D., Zheng S.L., Hawkins G.A., Ampleford E.J., et al. Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med 180 (2009) 929-935
25. Soderhall C., Marenholz I., Kerscher T., Ruschendorf F., Esparza-Gordillo J., Worm M., et al. Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol 5 (2007) e242
26. Blakey J.D., Sayers I., Ring S.M., Strachan D.P., and Hall I.P. Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958 Birth Cohort. Thorax 64 (2009) 381-387
27. Daley D., Lemire M., Akhabir L., Chan-Yeung M., He J.Q., McDonald T., et al. Analyses of associations with asthma in four asthma population samples from Canada and Australia. Hum Genet 125 (2009) 445-459
28. Hersh C.P., Raby B.A., Soto-Quiros M.E., Murphy A.J., Avila L., Lasky-Su J., et al. Comprehensive testing of positionally cloned asthma genes in two populations. Am J Respir Crit Care Med 176 (2007) 849-857
29. Denham S., Koppelman G.H., Blakey J., Wjst M., Ferreira M.A., Hall I.P., et al. Meta-analysis of genome-wide linkage studies of asthma and related traits. Respir Res 9 (2008) 38
30. Altshuler D., Brooks L.D., Chakravarti A., Collins F.S., Daly M.J., and Donnelly P. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
31. Altshuler D., Daly M.J., and Lander E.S. Genetic mapping in human disease. Science 322 (2008) 881-888
32. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9 (2008) 356-369
33. Hindorff LA, Junkins HA, Mehta JP, Manolio TA. A catalog of published genome-wide association studies. Available at: http://www.genome.gov/gwastudies. Accessed October 1, 2009.
34. Moffatt M.F., Kabesch M., Liang L., Dixon A.L., Strachan D., Heath S., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448 (2007) 470-473
35. Bouzigon E., Corda E., Aschard H., Dizier M.H., Boland A., Bousquet J., et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med 359 (2008) 1985-1994
36. Leung T.F., Sy H.Y., Ng M.C., Chan I.H., Wong G.W., Tang N.L., et al. Asthma and atopy are associated with chromosome 17q21 markers in Chinese children. Allergy 64 (2009) 621-628
37. Bisgaard H., Bonnelykke K., Sleiman P.M., Brasholt M., Chawes B., Kreiner-Moller E., et al. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am J Respir Crit Care Med 179 (2009) 179-185
38. Wu H., Romieu I., Sienra-Monge J.J., Li H., del Rio-Navarro B.E., and London S.J. Genetic variation in ORM1-like 3 (ORMDL3) and gasdermin-like (GSDML) and childhood asthma. Allergy 64 (2009) 629-635
39. Himes B.E., Hunninghake G.M., Baurley J.W., Rafaels N.M., Sleiman P., Strachan D.P., et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 84 (2009) 581-593
40. Hancock D.B., Romieu I., Shi M., Sienra-Monge J.J., Wu H., Chiu G.Y., et al. Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in Mexican children. PLoS Genet 5 (2009) e1000623
41. Gudbjartsson D.F., Bjornsdottir U.S., Halapi E., Helgadottir A., Sulem P., Jonsdottir G.M., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41 (2009) 342-347
42. Weidinger S., Gieger C., Rodriguez E., Baurecht H., Mempel M., Klopp N., et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 4 (2008) e1000166
43. Kim S.H., Cho B.Y., Park C.S., Shin E.S., Cho E.Y., Yang E.M., et al. Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. Clin Exp Allergy 39 (2009) 203-212
44. Esparza-Gordillo J., Weidinger S., Folster-Holst R., Bauerfeind A., Ruschendorf F., Patone G., et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 41 (2009) 596-601
45. Holloway J.W., and Koppelman G.H. 17q21 variants and asthma-questions and answers. N Engl J Med 359 (2008) 2043-2045
46. Galanter J., Choudhry S., Eng C., Nazario S., Rodriguez-Santana J.R., Casal J., et al. ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am J Respir Crit Care Med 177 (2008) 1194-1200
47. Tavendale R., Macgregor D.F., Mukhopadhyay S., and Palmer C.N. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J Allergy Clin Immunol 121 (2008) 860-863
48. Shimizu M., Matsuda A., Yanagisawa K., Hirota T., Akahoshi M., Inomata N., et al. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet 14 (2005) 2919-2927
49. Reijmerink N.E., Postma D.S., Bruinenberg M., Nolte I.M., Meyers D.A., Bleecker E.R., et al. Association of IL1RL1, IL18R1, and IL18RAP gene cluster polymorphisms with asthma and atopy. J Allergy Clin Immunol 122 (2008) 651-654 e8
50. Choi J.H., Nahm D.H., Kim S.H., Kim Y.S., Suh C.H., Park H.S., et al. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. Ann Allergy Asthma Immunol 93 (2004) 293-298
51. Maher B. Personal genomes: the case of the missing heritability. Nature 456 (2008) 18-21
52. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 461 (2009) 747-753
53. Frazer K.A., Murray S.S., Schork N.J., and Topol E.J. Human genetic variation and its contribution to complex traits. Nat Rev Genet 10 (2009) 241-251
54. 1000 genomes: A deep catalog of human genetic variation. Available at: http://www.1000genomes.org/page.php. Accessed October 1, 2009.
55. McCarroll S.A., Kuruvilla F.G., Korn J.M., Cawley S., Nemesh J., Wysoker A., et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 40 (2008) 1166-1174
56. Yang I.A., and Holloway J.W. Asthma: advancing gene-environment studies. Clin Exp Allergy 37 (2007) 1264-1266
57. Smit L.A., Siroux V., Bouzigon E., Oryszczyn M.P., Lathrop M., Demenais F., et al. CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults. Am J Respir Crit Care Med 179 (2009) 363-368
58. Bieli C., Eder W., Frei R., Braun-Fahrlander C., Klimecki W., Waser M., et al. A polymorphism in CD14 modifies the effect of farm milk consumption on allergic diseases and CD14 gene expression. J Allergy Clin Immunol 120 (2007) 1308-1315
59. Sharma S., Raby B.A., Hunninghake G.M., Soto-Quiros M., Avila L., Murphy A.J., et al. Variants in TGFB1, dust mite exposure, and disease severity in children with asthma. Am J Respir Crit Care Med 179 (2009) 356-362
60. Hunninghake G.M., Soto-Quiros M.E., Lasky-Su J., Avila L., Ly N.P., Liang C., et al. Dust mite exposure modifies the effect of functional IL10 polymorphisms on allergy and asthma exacerbations. J Allergy Clin Immunol 122 (2008) 93-98 e1-5
61. Kim Y., Park C.S., Shin H.D., Choi J.W., Cheong H.S., Park B.L., et al. A promoter nucleotide variant of the dendritic cell-specific DCNP1 associates with serum IgE levels specific for dust mite allergens among the Korean asthmatics. Genes Immun 8 (2007) 369-378
62. Yang I.A., Fong K.M., Zimmerman P.V., Holgate S.T., and Holloway J.W. Genetic susceptibility to the respiratory effects of air pollution. Thorax 63 (2008) 555-563
63. Salam M.T., Islam T., Gauderman W.J., and Gilliland F.D. Roles of arginase variants, atopy, and ozone in childhood asthma. J Allergy Clin Immunol 123 (2009) 596-602 e1-8
64. Islam T., Berhane K., McConnell R., Gauderman W.J., Avol E., Peters J.M., et al. Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax 64 (2009) 197-202
65. Schroer K.T., Biagini Myers J.M., Ryan P.H., Lemasters G.K., Bernstein D.I., Villareal M., et al. Associations between multiple environmental exposures and glutathione S-transferase P1 on persistent wheezing in a birth cohort. J Pediatr 154 (2008) 401-408 e1
66. Wu H., Romieu I., Sienra-Monge J.J., del Rio-Navarro B.E., Anderson D.M., Dunn E.W., et al. Parental smoking modifies the relation between genetic variation in tumor necrosis factor-alpha (TNF) and childhood asthma. Environ Health Perspect 115 (2007) 616-622
67. Davey Smith G., and Ebrahim S. What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures?. BMJ 330 (2005) 1076-1079
68. Sheehan N.A., Didelez V., Burton P.R., and Tobin M.D. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med 5 (2008) e177
69. Obermayer-Pietsch B.M., Bonelli C.M., Walter D.E., Kuhn R.J., Fahrleitner-Pammer A., Berghold A., et al. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res 19 (2004) 42-47
70. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
71. Yang I.A., Savarimuthu S., Kim S.T., Holloway J.W., Bell S.C., and Fong K.M. Gene-environmental interaction in asthma. Curr Opin Allergy Clin Immunol 7 (2007) 75-82
72. London S.J., and Romieu I. Gene by environment interaction in asthma (*). Annu Rev Public Health 30 (2009) 55-80
73. Breton C.V., Vora H., Salam M.T., Islam T., Wenten M., Gauderman W.J., et al. Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. Am J Respir Crit Care Med 179 (2009) 601-607
74. Kabesch M., Schedel M., Carr D., Woitsch B., Fritzsch C., Weiland S.K., et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 117 (2006) 269-274
75. Suttner K., Rosenstiel P., Depner M., Schedel M., Pinto L.A., Ruether A., et al. TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants. J Allergy Clin Immunol 123 (2009) 1062-1068 e1-8
76. Pykalainen M., Kinos R., Valkonen S., Rydman P., Kilpelainen M., Laitinen L.A., et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol 115 (2005) 80-87
77. Balaci L., Spada M.C., Olla N., Sole G., Loddo L., Anedda F., et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet 80 (2007) 1103-1114
78. Martinez F.D. CD14, endotoxin, and asthma risk: actions and interactions. Proc Am Thorac Soc 4 (2007) 221-225
79. Yang I.A., Fong K.M., Holgate S.T., and Holloway J.W. The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 6 (2006) 23-28
80. Bierbaum S., Nickel R., Koch A., Lau S., Deichmann K.A., Wahn U., et al. Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med 172 (2005) 1505-1509
81. Sutherland T.E., Maizels R.M., and Allen J.E. Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy 39 (2009) 943-955
82. Holgate S.T., Davies D.E., Powell R.M., Howarth P.H., Haitchi H.M., and Holloway J.W. Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. Eur Respir J 29 (2007) 793-803
83. Presland R.B., Coulombe P.A., Eckert R.L., Mao-Qiang M., Feingold K.R., and Elias P.M. Barrier function in transgenic mice overexpressing K16, involucrin, and filaggrin in the suprabasal epidermis. J Invest Dermatol 123 (2004) 603-606
84. Brown S.J., and McLean W.H. Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 129 (2009) 543-552
85. Sandilands A., Sutherland C., Irvine A.D., and McLean W.H. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 122 (2009) 1285-1294
86. Baurecht H., Irvine A.D., Novak N., Illig T., Buhler B., Ring J., et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 120 (2007) 1406-1412
87. Henderson J., Northstone K., Lee S.P., Liao H., Zhao Y., Pembrey M., et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 121 (2008) 872-877 e9
88. Palmer C.N.A., Ismail T., Lee S.P., Terron-Kwiatkowski A., Zhao Y., Liao H., et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol 120 (2007) 64-68
89. Weidinger S., O'Sullivan M., Illig T., Baurecht H., Depner M., Rodriguez E., et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 121 (2008) 1203-1209 e1
90. Marenholz I., Nickel R., Ruschendorf F., Schulz F., Esparza-Gordillo J., Kerscher T., et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118 (2006) 866-871
91. Fallon P.G., Sasaki T., Sandilands A., Campbell L.E., Saunders S.P., Mangan N.E., et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41 (2009) 602-608
92. Smith M., Tourigny M.R., Noakes P., Thornton C.A., Tulic M.K., and Prescott S.L. Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function. J Allergy Clin Immunol 121 (2008) 1460-1466 e1-7
93. Dezateux C., and Stocks J. Lung development and early origins of childhood respiratory illness. Br Med Bull 53 (1997) 40-57
94. Haland G., Carlsen K.C., Sandvik L., Devulapalli C.S., Munthe-Kaas M.C., Pettersen M., et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 355 (2006) 1682-1689
95. Palmer L.J., Rye P.J., Gibson N.A., Burton P.R., Landau L.I., and Lesouef P.N. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med 163 (2001) 37-42
96. Lucas J.S., Inskip H.M., Godfrey K.M., Foreman C.T., Warner J.O., Gregson R.K., et al. Small size at birth and greater postnatal weight gain: relationships to diminished infant lung function. Am J Respir Crit Care Med 170 (2004) 534-540
97. Lowe L., Murray C.S., Custovic A., Simpson B.M., Kissen P.M., and Woodcock A. Specific airway resistance in 3-year-old children: a prospective cohort study. Lancet 359 (2002) 1904-1908
98. Haitchi H.M., Powell R.M., Shaw T.J., Howarth P.H., Wilson S.J., Wilson D.I., et al. ADAM33 expression in asthmatic airways and human embryonic lungs. Am J Respir Crit Care Med 171 (2005) 958-965
99. Simpson A., Maniatis N., Jury F., Cakebread J.A., Lowe L.A., Holgate S.T., et al. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med 172 (2005) 55-60
100. Henrichsen C.N., Chaignat E., and Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet 18 (2009) R1-R8
101. McCarthy M.I., and Hirschhorn J.N. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17 (2008) R156-R165
102. Jirtle R.L., and Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 8 (2007) 253-262
103. Benn C.S., Jeppesen D.L., Hasselbalch H., Olesen A.B., Bjorksten B., Lisse I., et al. Thymus size and head circumference at birth and the development of allergic disease. Clin Exp Allergy 31 (2001) 1862-1866
104. Fergusson D.M., Crane J., Beasley R., and Horwood L.J. Perinatal factors and atopic disease in childhood. Clin Exp Allergy 27 (2006) 1394-1401
105. Godfrey K.M., Barker D.J., and Osmond C. Disproportionate fetal growth and raised IgE concentration in adult life. Clin Exp Allergy 24 (2006) 641-648
106. Baccarelli A., Wright R.O., Bollati V., Tarantini L., Litonjua A.A., Suh H.H., et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 179 (2009) 572-578
107. Li Y., Langholz B., Salam M.T., and Gilliand F.D. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest 127 (2005) 1232-1241
108. Hollingsworth J.W., Maruoka S., Boon K., Garantziotis S., Li Z., Tomfohr J., et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 118 (2008) 3462-3469
109. Miller R.L., and Ho S.M. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 177 (2008) 567-573
110. Burke W., Fesinmeyer M., Reed K., Hampson L., and Carlsten C. Family history as a predictor of asthma risk. Am J Prev Med 24 (2003) 160-169
111. Koppelman G.H., te Meerman G.J., and Postma D.S. Genetic testing for asthma. Eur Respir J 32 (2008) 775-782
112. Janssens A.C., Aulchenko Y.S., Elefante S., Borsboom G.J., Steyerberg E.W., and van Duijn C.M. Predictive testing for complex diseases using multiple genes: fact or fiction?. Genet Med 8 (2006) 395-400
113. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359 (2008) 2220-2232
114. Meigs J.B., Shrader P., Sullivan L.M., McAteer J.B., Fox C.S., Dupuis J., et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359 (2008) 2208-2219
115. Narayan K.M., and Weber M.B. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 360 (2009) 136-1
116. Holloway J.W., Yang I.A., and Holgate S.T. Interpatient variability in rates of asthma progression: can genetics provide an answer?. J Allergy Clin Immunol 121 (2008) 573-579
117. Marenholz I., Kerscher T., Bauerfeind A., Esparza-Gordillo J., Nickel R., Keil T., et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol 123 (2009) 911-916
118. Busse W.W., Israel E., Nelson H.S., Baker J.W., Charous B.L., Young D.Y., et al. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am J Respir Crit Care Med 178 (2008) 1002-1008
119. Nair P., Pizzichini M.M., Kjarsgaard M., Inman M.D., Efthimiadis A., Pizzichini E., et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 360 (2009) 985-993
120. Flood-Page P., Swenson C., Faiferman I., Matthews J., Williams M., Brannick L., et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 176 (2007) 1062-1071
121. Wenzel S.E., Barnes P.J., Bleecker E.R., Bousquet J., Busse W., Dahlen S.E., et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 179 (2009) 549-558
122. Anderson G.P. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372 (2008) 1107-1119
123. Haldar P., Pavord I.D., Shaw D.E., Berry M.A., Thomas M., Brightling C.E., et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178 (2008) 218-224
124. Wenzel S.E., and Busse W.W. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 119 (2007) 14-23
125. Lima J.J., Blake K.V., Tantisira K.G., and Weiss S.T. Pharmacogenetics of asthma. Curr Opin Pulm Med 15 (2009) 57-62
126. Wechsler M.E., Lehman E., Lazarus S.C., Lemanske Jr. R.F., Boushey H.A., Deykin A., et al. β-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 173 (2006) 519-526
127. Bleecker E.R., Postma D.S., Lawrance R.M., Meyers D.A., Ambrose H.J., and Goldman M. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 370 (2007) 2118-2125
128. Bleecker E.R., Yancey S.W., Baitinger L.A., Edwards L.D., Klotsman M., Anderson W.H., et al. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. J Allergy Clin Immunol 118 (2006) 809-816
129. Hawkins G.A., Weiss S.T., and Bleecker E.R. Clinical consequences of ADRbeta2 polymorphisms. Pharmacogenomics 9 (2008) 349-358
130. Litonjua A.A., Lasky-Su J., Schneiter K., Tantisira K.G., Lazarus R., Klanderman B., et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 178 (2008) 688-694
131. Tantisira K.G., Lake S., Silverman E.S., Palmer L.J., Lazarus R., Silverman E.K., et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 13 (2004) 1353-1359
132. Dijkstra A., Koppelman G.H., Vonk J.M., Bruinenberg M., Schouten J.P., and Postma D.S. Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms. J Allergy Clin Immunol 121 (2008) 1510-1513
133. Hawkins G.A., Lazarus R., Smith R.S., Tantisira K.G., Meyers D.A., Peters S.P., et al. The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J Allergy Clin Immunol 123 (2009) 1376-1383 e7
134. Duroudier N.P., Tulah A.S., and Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 64 (2009) 823-839
135. Lima J.J., Zhang S., Grant A., Shao L., Tantisira K.G., Allayee H., et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173 (2006) 379-385
136. Klotsman M., York T.P., Pillai S.G., Vargas-Irwin C., Sharma S.S., van den Oord E.J., et al. Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet Genomics 17 (2007) 189-196
137. Tantisira K.G., Lima J., Sylvia J., Klanderman B., and Weiss S.T. 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci. Pharmacogenet Genomics 19 (2009) 244-247